URGENT UPDATE: A 22-year-old epilepsy patient from Newcastle is receiving new hope as he participates in a pioneering clinical trial involving a revolutionary brain implant. Adam Atkinson, who has battled debilitating daily seizures for years, has undergone surgery at the Royal Victoria Infirmary (RVI) to fit this cutting-edge device.
After suffering from a rare condition known as seronegative autoimmune encephalitis, Adam spent an agonizing three months in a coma seven years ago. While he awoke and returned home, he was left with a severe brain injury and a form of refractory epilepsy that does not respond to traditional medications.
Adam’s mother, Victoria, detailed the overwhelming impact of his condition, stating, “Adam’s seizures have been almost daily since his brain injury in 2018. They affect every aspect of Adam’s life.” The family struggled to accurately track these seizures until now.
The innovative brain implant utilizes advanced brainwave monitoring technology, enabling real-time data collection on the frequency and intensity of Adam’s seizures. For the first time, doctors can accurately monitor his condition without relying solely on seizure diaries, which can be unreliable.
Victoria expressed her excitement about Adam’s inclusion in the trial: “Before the implant, we sometimes didn’t know when Adam had a seizure, so the diary wasn’t always accurate. We hope this study will help us improve his treatment and possibly lead to new alternative treatments.” Already, the implant has revealed that Adam experiences seizures during sleep—information that would have taken months to gather through traditional monitoring methods.
Dr. Rhys Thomas, a consultant neurologist involved in the trial, emphasized the significance of the study: “This study allows us to monitor people as they go about their daily lives, for up to 24 hours a day, to get a full picture of their brain’s activities.” The RVI is among just five hospitals nationwide participating in this critical trial.
Adam shared his feelings about the implant: “It’s exciting; it really gives you hope. And it doesn’t impact my life so much.” The potential for future treatments is now within reach, offering a glimmer of hope for Adam and others living with similar conditions.
Meanwhile, Judith Nelson, another trial participant, expressed optimism about the implant’s potential: “I hope this research will lead to new equipment in the future that will help many people with epilepsy be more prepared for the effects that their unseen medical condition can cause.” Judith has endured her own struggles with epilepsy for the past 13 years, facing numerous injuries due to her seizures.
The team at RVI has successfully implanted devices in five patients, including Adam, aiming to revolutionize how epilepsy is monitored and treated. With over 630,000 people affected by epilepsy in the UK alone, the urgency for effective solutions is palpable.
Victoria concluded, “We have only had it in around two months, but there’s already information coming. This means we can see more about what helps and hopefully we will be able to get him onto a minimal amount of medication.” As Adam continues his journey, the promise of this new technology shines bright, offering hope not just for him but for countless others fighting epilepsy.
Stay updated on the latest developments in this groundbreaking trial and other breaking news by signing up for our free ChronicleLive Daily newsletter.
